Provided by Tiger Fintech (Singapore) Pte. Ltd.

TG Therapeutics

43.44
-1.9300-4.25%
Post-market: 43.600.1625+0.37%19:56 EDT
Volume:4.17M
Turnover:184.69M
Market Cap:6.90B
PE:289.60
High:45.97
Open:45.37
Low:42.96
Close:45.37
Loading ...
Mar 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 10, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Aug 04, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
Jun 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2023

Major Issues Report

8-K - Current report
Apr 03, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 01, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]